Phelan, M. M., Caamaño-Gutiérrez, E., Gant, M. S., Grosman, R. X., & Madine, J. (2017). Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein. Metabolomics.
Chicago-stil citatPhelan, M. M., E. Caamaño-Gutiérrez, M. S. Gant, R. X. Grosman, och J. Madine. "Using an NMR Metabolomics Approach to Investigate the Pathogenicity of Amyloid-beta and Alpha-synuclein." Metabolomics 2017.
MLA-referensPhelan, M. M., et al. "Using an NMR Metabolomics Approach to Investigate the Pathogenicity of Amyloid-beta and Alpha-synuclein." Metabolomics 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.